Ignite Creation Date:
2025-12-24 @ 7:42 PM
Ignite Modification Date:
2025-12-27 @ 1:28 AM
Study NCT ID:
NCT05533203
Status:
UNKNOWN
Last Update Posted:
2023-01-23
First Post:
2022-09-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety of Prodencel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC)
Sponsor:
Shanghai Humantech Biotechnology Co. Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-08
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-01
First Submit QC Date:
None
Study First Post Date:
2022-09-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-19
Last Update Post Date:
2023-01-23
Last Update Post Date Type:
ACTUAL